- RecruitingPHASE3
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
This study looks at a new treatment for certain types of advanced bowel and pancreatic cancers (GEP-NETs). It compares a combination of a new drug ([177Lu]Lu-DOTA-TATE) and an existing one (Octreotide LAR) to Octreotide LAR alone, checking how well it works and if it's safe.
For: Somatostatin Receptor Positive (SSTR+) · Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)United States · Canada · China - Active not recruitingPHASE3
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
This study is testing a new medicine, CAM2029, for a type of cancer called GEP-NET. It compares CAM2029 to existing treatments, octreotide LAR and lanreotide ATG, to see if it's more effective and safe for advanced GEP-NET.
For: Gastro-enteropancreatic Neuroendocrine TumorUnited States · Australia · Belgium